Skip to content

MassBio

Massachusetts Biotechnology Council

Open search form
  • Sign In
  • Become a Member
  • MB Vision
  • Members
    • Become a Member
      • Types & Rates
    • Benefits
      • Savings and Rewards
    • Member News
    • Member Events
    • Career Center
    • Directory
    • Pay Company Dues
    • FAQs
  • Events
    • Upcoming
    • Types of Events
    • Sponsorship Opportunities
    • The State of Possible Conference
    • Align Summit
    • Member Events
  • Innovation
    • About
    • Drive
      • Application
      • Alumni
      • Partners – MassBio
      • Partners – SCbio
      • Get Involved
      • FAQs
    • CEO & Founder Link
    • Align Summit
    • Partnering
    • Sponsorship Opportunities
  • Savings
    • MassBioEdge
  • Conference Center
    • About MassBioHub
    • Packages & Special Offers
    • Venue Specifications
    • Reserve Today
  • Policy & Advocacy
    • Policy & Advocacy Efforts
    • Diversity, Equity, and Inclusion
      • DEI Report
      • Resource Center
      • Open Letter 2.0
      • Bioversity
    • Economic Development
      • BioReady® Communities
    • Workforce Development
      • Bioversity
    • Vision 2030
    • This is the place.
    • Industry Reports
      • Federal Actions Impact Report
      • Industry Snapshot
      • Biopharma Funding Report
      • DEI Report
      • MA Life Sciences Workforce
  • About
    • About MassBio
    • News & Thought Leadership
    • MB Vision
    • The Studio at Kendall Square
    • Sponsorship Opportunities
    • Staff
    • Board
    • Contact Us
  • Sign In
  • Become a Member
  • MB Vision
Open search form

Member Directory

Click to Open Main Menu

Prudentia Sciences

Associate Industry | Information Technology
Cambridge, MA 617-823-0290 Website LinkedIn

Overview

Prudentia Sciences is the AI-powered operating system for pharma, biotech, and investor deal-making in the life sciences space.

Our platform enables users to seamlessly integrate disparate datasources, including virtual data rooms, public data sources, and licensed data. It then intelligently and rapidly assesses these sources and answers hundreds of questions across all scientific domains (eg. CMC, Safety/Toxicology, Discovery, Regulatory, etc.). The result is a in-depth, highly scientific diligence on target assets.

Emerging biotech companies are leveraging this platform to rapidly assess their science, understand and identify potential risks, and think critically about how best to stage their assets as they seek external investment.

See all Members

Massachusetts Biotechnology Council

700 Technology Square, 5th Floor
Cambridge, MA 02139
617.674.5100

  • News & Thought Leadership
  • Join Email List
  • Pay Company Dues
  • Join Today
  • Contact
  • Privacy Policy
  • © 2026 All Rights Reserved